Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this live activity for a maximum of 13.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physicians' Education Resource®, LLC, is approved by the California Board of Registered Nursing, Provider #16669, for 13.5 Contact Hours.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Astellas; Exelixis, Inc.; Genomic Health, Inc.; Merck & Co., Inc.; Pfizer Inc.; Sanofi Genzyme; and Seattle Genetics, Inc.

New York GU 13th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

New York GU 13th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies

View Live Broadcast

March 13-14, 2020

The Roosevelt Hotel
45 East 45th Street & Madison Avenue
New York, New York 10017

The Conference will go on as scheduled!

Physicians’ Education Resource®, LLC, understands the concerns surrounding the outbreak and spread of the coronavirus (COVID-19) currently affecting several countries. After monitoring the situation and information being shared by the CDC, and taking into account current travel restrictions, we have decided that the New York GU 13th Annual Interdisciplinary Prostate Cancer Congress®, and Other Genitourinary Malignancies will go on as scheduled. Be assured that there is nothing more important to us than the safety of our participants; therefore, we have worked with our host hotel and taken steps to implement additional precautions on-site to keep our attendees safe at this year’s conference. We look forward to seeing you there.

2020 Activity Overview

New York GU 13th Annual Interdisciplinary Prostate Cancer Congress® and Other Genitourinary Malignancies will provide a comprehensive overview of genitourinary malignancies with a focus on urothelial, prostate, and renal cancers. Faculty will present brief and insightful presentations covering a range of topics that will include diagnostic molecular pathology, current and evolving therapeutic strategies, and best practices for managing advanced disease. You will have the opportunity to hear the expert faculty as they engage in challenging case debates and gain insight into some of the most challenging issues facing your clinical practice. You will leave with the confidence to maintain current standards of care and implement the best new strategies into your clinical practice.

You won’t want to miss this conference! Now in its 13th year, the 2020 New York GU™ meeting offers you the opportunity to advance your understanding and knowledge of state-of-the-art care for patients with genitourinary malignancies.

Acknowledgement of Commercial Support

This activity is supported by educational grants from Astellas; Exelixis, Inc.; Genomic Health, Inc.; Merck & Co., Inc.; Pfizer Inc.; Sanofi Genzyme; and Seattle Genetics, Inc.

Target Audience

This educational activity is directed toward medical, surgical, and radiation oncologists involved in the treatment of patients with GU malignancies. Urologists, fellows, nurse practitioners, nurses, physician assistants, pharmacists, researchers, nuclear medicine physicians, and other healthcare professionals interested in the treatment of GU malignancies may also participate.

Learning Objectives

After this activity, participants should be better prepared to:

  1. Outline the molecular pathology of GU tumors and current and emerging diagnostic concepts in GU cancers
  2. Describe current approaches and practice-changing clinical evidence for the management of patients with GU malignancies across multiple lines of care
  3. Explain strategies for monitoring, recognizing, and mitigating treatment-related toxicities associated with therapies used for GU cancers
  4. Determine how recent landmark findings from trials conducted among patients with GU malignancies can be placed in the context of evolving treatment paradigms in urology and medical oncology practices

Hot Topics for 2020

  • Applying molecular markers toward decision making for GU cancers
  • Updates in clinical immunotherapy across tumor types
  • Best practices for advanced bladder cancer (BC), renal cell carcinoma (RCC), and prostate cancer (PC)
  • Emerging therapies in GU cancers
  • The latest progress in next-generation imaging for PC
  • New concepts for screening in PC
  • Updates in PARP Inhibitors for PC
  • Practical guidance on managing early BC
  • Monotherapy versus combination therapy update in RCC
  • Challenging case debates
  • And more!

Program Co-Chairs

Leonard G. Gomella
Leonard G. Gomella, MD, FACS
The Bernard W. Godwin, Jr., Professor of Prostate Cancer
Chairman, Department of Urology
Jefferson Medical College
Associate Director, Sidney Kimmel Cancer Center
Clinical Director, Sidney Kimmel Cancer Center Network
Thomas Jefferson University
Philadelphia, PA
Daniel P. Petrylak
Daniel P. Petrylak, MD
Professor of Medicine (Medical Oncology) and Urology
Yale School of Medicine
Director, Prostate and Genitourinary Medical Oncology
Director, Prostate Cancer Translational Research Group
Yale Cancer Center
New Haven, CT



Registration fees include breakfast, breaks, and e-syllabus materials.

2 Ways to Register

  1. Online: Click here.
  2. Phone: Please call +1-(888)-949-0045 or +1-609-378-3701 (credit cards only).

Physicians' Education Resource® - NYGU20
2 Clarke Drive
Suite 100
Cranbury, NJ 08512

Registration Fees - $50.00

For registration assistance, please email, or call +1-(888)-949-0045 or +1-(609)-378-3701.

A cancellation fee of 25% will be assessed on refunds requested prior to January 3, 2020, and a 50% fee on refunds requested on January 4, 2020, through February 12, 2020. No refunds will be made after February 12, 2020. There is no charge for substitution. Substitutions can only be applied to the same conference, and only 2 substitutions will be honored.

In the event of a meeting cancellation, full refunds will be processed within 30 days of the cancellation date.

Physicians' Education Resource®, LLC (PER®) fully complies with the legal requirements of the Americans with Disabilities Act (ADA) and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please notify us in order to receive service. Please call +1-(609)-378-3701.

PER® reserves the exclusive rights to all recordings or reproductions of the conference and supporting materials. Unauthorized recording, by any means, is expressly prohibited. This includes, but is not limited to, recording of presentations or reproductions of supporting audio/visual materials, exhibits, and other supporting continuing education materials.

By attending a PER® conference, meeting or related activity ("Events"), all participants, attendees, exhibitors, sponsors, and guests ("you") create an agreement between you and PER® regarding the use and distribution of your image, including but not limited to your name, voice, and likeness ("Image").  By attending the Events, you acknowledge and agree that photographs, video, and/or audio recordings may be taken of you and you grant permission to PER® (and its agents) to utilize, in perpetuity, your Image in any electronic or print distribution, or by other means hereinafter created, both now and in the future, for any lawful purpose as determined by PER®.

Meeting information is accurate at the time of posting.

PER® complies with the Physician Payments Sunshine Act as part of the Affordable Care Act. Accordingly, we may be required to collect information on transfers of value provided to any covered recipient under the Act.



You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information

Registration Information

In case of onsite emergency:

Professional Information


Calendar of Events
Filter By